Close
Help




JOURNAL

Ophthalmology and Eye Diseases

96,862 Journal Article Views | Journal Analytics

Acute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel?

Submit a Paper



Publication Date: 19 Apr 2012

Type: Review

Journal: Ophthalmology and Eye Diseases

Citation: Ophthalmology and Eye Diseases 2012:4 23-34

doi: 10.4137/OED.S7267

Abstract

Herpes simplex keratitis (HSK) is a major cause of corneal blindness in the world. Following the primary infection, the virus enters into a latent phase. Recurrent infectious or immune keratitis cause structural damage to the cornea, scarring, and may lead to blindness. Several commercially available topical and oral antiviral drugs for HSK are currently available. However, toxicity and low patient compliance hamper their use in HSK. Further, oral antiviral drugs alone are not always effective in HSK. Thus, there had been a need for safe and effective topical antiviral agents against HSK. Systemic ganciclovir has been in use for the treatment of cytomegalovirus infections. Recently, topical ganciclovir has become available for use in patients with HSK. Ganciclovir 0.15% ophthalmic gel has been shown to be both safe and effective against viruses of the herpes family. Topical ganciclovir ophthalmic gel is well tolerated and does not cause significant toxic effects on the ocular surface. Several multicenter studies have revealed the potential role of ganciclovir ophthalmic gel in the treatment and prophylaxis of epithelial HSK. In this paper, we have reviewed the pharmacology, efficacy, side effects, and the role of ganciclovir ophthalmic gel 0.15% in the treatment of acute herpetic keratitis.


Downloads

PDF  (843.70 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML






What Your Colleagues Say About Ophthalmology and Eye Diseases
The publishing process was fast and convenient.  The journal staff were extremely helpful and prompt in responding to questions and issues related to the submission.  The online submission and revision process was easy and staff were readily available to answer any questions.  The reviewers' comments were insightful, very constructive and extremely helpful.  The author interface is user-friendly. The publishing process is fast and convenient.  I highly recommend others practitioners and researchers to consider Libertas Academica ...
Dr Elena Pacella (Sapienza University of Rome, Italy)
More Testimonials

Quick Links


New article and journal news notification services